Followers | 435 |
Posts | 57599 |
Boards Moderated | 5 |
Alias Born | 01/09/2007 |
Monday, March 16, 2015 7:01:03 AM
link
and your response ...
clearly at cross purposes >> *my* reference to the use of the word endeavors and how spelled is noted
*rather clearly* >> in one of the 2 links
Posted On: 03/04/2015 10:00:49 AM
as for this ..
====
thank you for clarifying >> *position* >> so early into this SMB >> *discussion* .. lol
and as for this ..
only unless 8k'd by mgmt (which means P2O's *legal* has signed off on with 8k filed)
would i have an interest
because >>
i don't consider RH or P2O's legal >> to be >> and i quote >> company shills
if anything RH has gone out of his way to *not* promote all aspects >> P2O >> since his install as Ceo
which is why those of us who are aware of *how* disruptors >> *work* >> recognize >> realistic
time lines (Eco's LLC is a perfect example being created in March 2014 .. exactly one year ago)
and as previously *noted* >> here >> the following (material) events
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111672796
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111752973
lastly >> my *focus* as noted so many times since P2O's Jan PR >> is on who Eco is a front for :)
because as *most* recognize >> there is no way that Mark Ragus as the president of one of Cignet's
holding co.s >> doesn't have the *awareness and approval* of both Richard Crawford and Patrick
Greene
gee *green* ;)
hmmmm
domestic footprint established + global footprint established = a landrush for P2O prox
but as always .. i'll take it one step at a time :)
also duly noted *here*
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111752462
and speaking of *food for thought* >> Cignet (Crawford and Greene) imo is worth doing the DD on
re: *overlap* to all sorts of *turnkey* >> SOLUTIONS >> in the alternative energy *technologies* (plural)
2.8.15
4kids
all jmo
10/5/07 -- there are no coincidences here ...
oh and like many other longs .. not selling at this level --
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM